Company

Protego Bio

Biotechnology Research 10945 Vista Sorrento Pkwy 22 employees

Employees: 22
Contacts: 3
Emails: 3
Phones: 1

www.protegobio.com LinkedIn

Protego Bio Overview

Headquarters: 10945 Vista Sorrento Pkwy
Website: www.protegobio.com
Industry: Biotechnology Research
Employees: 22
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Protego Bio

Protego focuses on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. We are exploring monogenetic protein misfolding diseases that cause myopathy, cardiomyopathy, stroke, renal disease, retinal diseases, channelopathies, and various degenerative diseases. Our approach builds on the proven pharmacological chaperones approach previously exemplified by tafamidis, which was discovered and developed by our cofounders Dr. Jeffery W. Kelly and Dr. Richard Labaudinière, for the treatment of transthyretin amyloidosis.

Protego Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Protego Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mike Petrassi		Cardiff-by-the-sea, California, United States	Email
David M. (Dave) Aurich, Ph.d.	Associate Dean of Students at College of Charleston		View
Arjun S.		Newark, California, United States	Email Phone
Helen S. Kim		Santa Monica, California, United States	Email